Back to results
US 2014/0154279 A1Published application
Peptides capable of modulating the function of tirc7
AssigneeCellAct Pharma GmbH
InventorNalân UTKU
Life of this patent
Estimating the term…
Abstract
Provided are peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from the third extracellular domain of T-cell immune response cDNA7 (TIRC7) costimulatory molecule are described. Compositions comprising such peptides and their use for the treatment of immune diseases are provided.
Claims10
A peptide capable of inhibiting proliferation of peripheral blood mononuclear cells, comprising a fragment of the amino acid sequence from the third extracellular domain of T cell immune response cDNA 7 protein.
Dependencies are inferred from the claim text.